Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone for Repetitive Behaviors in Children with ASD
NCT01171937Phase 2Completed
- Sponsor
- University of California, Los Angeles
- Start
- Sep 2008
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Autism Spectrum Disorder (ASD) comparing Risperidone with Placebo (2 arms). Primary endpoint: Aberrant Behavior Checklist at 5 years. Started Sep 2008; status: completed.
02
Drugs
risperidone
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT01171937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01171937.